Cargando…
Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection
INTRODUCTION: Remdesivir has proven to have benefits against COVID-19 infection. However, data supporting drug-drug interactions are insufficient. Clinicians have noticed that calcineurin inhibitor (CNI) levels tend to change after starting remdesivir. This retrospective study aimed to evaluate the...
Autores principales: | Habeeb, Ehsan, Gabardi, Steven, Townsend, Keri, Kim, Miae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148982/ https://www.ncbi.nlm.nih.gov/pubmed/37360819 http://dx.doi.org/10.1016/j.ekir.2023.04.028 |
Ejemplares similares
-
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
por: Buxeda, Anna, et al.
Publicado: (2021) -
Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
por: Lai, Elaine F., et al.
Publicado: (2022) -
Remdesivir resistance in transplant recipients with persistent COVID-19
por: Hogan, John I, et al.
Publicado: (2022) -
Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021) -
Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)